Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793281175> ?p ?o ?g. }
- W2793281175 endingPage "688" @default.
- W2793281175 startingPage "680" @default.
- W2793281175 abstract "Abstract Background: Chemoresistance is a major challenge in ovarian cancer treatment, resulting in poor survival rates. Identifying markers of treatment response is imperative for improving outcome while minimizing unnecessary side effects. We have previously demonstrated that expression of transducin-like enhancer of split 3 (TLE3) is associated with favorable progression-free survival in taxane-treated ovarian cancer patients with nonserous histology. The purpose of this study was to perform an independent evaluation of the association of TLE3 expression with response to taxane-based chemotherapy in nonserous ovarian cancer, to validate its role as a potential therapeutic response marker for taxane-based chemotherapy. Methods: We performed immunohistochemical staining of TLE3 on ovarian cancer specimens from the Australian Ovarian Cancer Study, the Westmead Gynaecological Oncology Biobank, and Memorial Sloan Kettering Cancer Center. Progression-free survival and overall survival were assessed to validate an association between TLE3 expression and response to taxane therapy that we previously observed in a smaller study. Results: Expression of TLE3 was associated with favorable outcome only in patients who had received paclitaxel as part of their treatment regimen for both 3-year progression-free survival (n = 160; HR, 0.56; P = 0.03) and 5-year overall survival (HR, 0.53; P = 0.04). Further analysis revealed that the predictive association between TLE3 expression and outcome was strongest in tumors with clear cell histology. Conclusions: The association between high TLE3 expression and a favorable response to taxane-containing chemotherapy regimens was validated in patients with nonserous ovarian cancer. Impact: TLE3 expression may serve as a marker of chemosensitivity in taxane-treated patients with nonserous histologies. Cancer Epidemiol Biomarkers Prev; 27(6); 680–8. ©2018 AACR." @default.
- W2793281175 created "2018-03-29" @default.
- W2793281175 creator A5000030462 @default.
- W2793281175 creator A5008006004 @default.
- W2793281175 creator A5023643377 @default.
- W2793281175 creator A5025082628 @default.
- W2793281175 creator A5028987280 @default.
- W2793281175 creator A5050390957 @default.
- W2793281175 creator A5053542215 @default.
- W2793281175 creator A5055849515 @default.
- W2793281175 creator A5057552010 @default.
- W2793281175 creator A5074802129 @default.
- W2793281175 creator A5076598668 @default.
- W2793281175 creator A5089061061 @default.
- W2793281175 date "2018-05-31" @default.
- W2793281175 modified "2023-10-16" @default.
- W2793281175 title "Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study" @default.
- W2793281175 cites W1195715571 @default.
- W2793281175 cites W1781764024 @default.
- W2793281175 cites W1969848618 @default.
- W2793281175 cites W1978728170 @default.
- W2793281175 cites W2002710053 @default.
- W2793281175 cites W2004074366 @default.
- W2793281175 cites W2013638309 @default.
- W2793281175 cites W2035081378 @default.
- W2793281175 cites W2055397209 @default.
- W2793281175 cites W2071496368 @default.
- W2793281175 cites W2080442030 @default.
- W2793281175 cites W2099562503 @default.
- W2793281175 cites W2135387903 @default.
- W2793281175 cites W2136662615 @default.
- W2793281175 cites W2168577971 @default.
- W2793281175 cites W2171056103 @default.
- W2793281175 cites W2305551225 @default.
- W2793281175 cites W2328421677 @default.
- W2793281175 cites W2341746233 @default.
- W2793281175 cites W2527248094 @default.
- W2793281175 cites W2557243447 @default.
- W2793281175 cites W2591235712 @default.
- W2793281175 cites W2751576284 @default.
- W2793281175 cites W4211170507 @default.
- W2793281175 cites W4233798790 @default.
- W2793281175 doi "https://doi.org/10.1158/1055-9965.epi-17-1101" @default.
- W2793281175 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5984690" @default.
- W2793281175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29531130" @default.
- W2793281175 hasPublicationYear "2018" @default.
- W2793281175 type Work @default.
- W2793281175 sameAs 2793281175 @default.
- W2793281175 citedByCount "2" @default.
- W2793281175 countsByYear W27932811752020 @default.
- W2793281175 countsByYear W27932811752022 @default.
- W2793281175 crossrefType "journal-article" @default.
- W2793281175 hasAuthorship W2793281175A5000030462 @default.
- W2793281175 hasAuthorship W2793281175A5008006004 @default.
- W2793281175 hasAuthorship W2793281175A5023643377 @default.
- W2793281175 hasAuthorship W2793281175A5025082628 @default.
- W2793281175 hasAuthorship W2793281175A5028987280 @default.
- W2793281175 hasAuthorship W2793281175A5050390957 @default.
- W2793281175 hasAuthorship W2793281175A5053542215 @default.
- W2793281175 hasAuthorship W2793281175A5055849515 @default.
- W2793281175 hasAuthorship W2793281175A5057552010 @default.
- W2793281175 hasAuthorship W2793281175A5074802129 @default.
- W2793281175 hasAuthorship W2793281175A5076598668 @default.
- W2793281175 hasAuthorship W2793281175A5089061061 @default.
- W2793281175 hasBestOaLocation W27932811751 @default.
- W2793281175 hasConcept C121608353 @default.
- W2793281175 hasConcept C126322002 @default.
- W2793281175 hasConcept C143998085 @default.
- W2793281175 hasConcept C2777511904 @default.
- W2793281175 hasConcept C2780427987 @default.
- W2793281175 hasConcept C2781413609 @default.
- W2793281175 hasConcept C530470458 @default.
- W2793281175 hasConcept C71924100 @default.
- W2793281175 hasConceptScore W2793281175C121608353 @default.
- W2793281175 hasConceptScore W2793281175C126322002 @default.
- W2793281175 hasConceptScore W2793281175C143998085 @default.
- W2793281175 hasConceptScore W2793281175C2777511904 @default.
- W2793281175 hasConceptScore W2793281175C2780427987 @default.
- W2793281175 hasConceptScore W2793281175C2781413609 @default.
- W2793281175 hasConceptScore W2793281175C530470458 @default.
- W2793281175 hasConceptScore W2793281175C71924100 @default.
- W2793281175 hasFunder F4320320543 @default.
- W2793281175 hasFunder F4320334705 @default.
- W2793281175 hasFunder F4320337351 @default.
- W2793281175 hasFunder F4320338280 @default.
- W2793281175 hasIssue "6" @default.
- W2793281175 hasLocation W27932811751 @default.
- W2793281175 hasLocation W27932811752 @default.
- W2793281175 hasLocation W27932811753 @default.
- W2793281175 hasLocation W27932811754 @default.
- W2793281175 hasOpenAccess W2793281175 @default.
- W2793281175 hasPrimaryLocation W27932811751 @default.
- W2793281175 hasRelatedWork W1966409175 @default.
- W2793281175 hasRelatedWork W1995085344 @default.
- W2793281175 hasRelatedWork W2024820134 @default.
- W2793281175 hasRelatedWork W2046833524 @default.
- W2793281175 hasRelatedWork W2055865927 @default.
- W2793281175 hasRelatedWork W2085844047 @default.